Jul 2 |
Altimmune to Participate at Leerink Partners Therapeutics Forum
|
Jun 26 |
Altimmune CFO Richard Eisenstadt passes away
|
Jun 26 |
Altimmune Mourns Passing of Chief Financial Officer, Richard Eisenstadt
|
Jun 24 |
Crypto under pressure, Good Buy or Goodbye: Market Domination
|
Jun 24 |
Altimmune reports positive results in weight-loss drug trial
|
Jun 24 |
Altimmune: Lean Muscle Fat Data Sends Stock Soaring - Competitors Will Take Note
|
Jun 24 |
Biggest stock movers today: Crypto stocks, AFRM, ALNY, and more
|
Jun 24 |
Altimmune jumps 13% on phase 2 pemvidutide results for obesity
|
Jun 23 |
Altimmune Presents Data from Phase 2 MOMENTUM Trial of Pemvidutide in Obesity during Oral Presentation at the American Diabetes Association’s 84th Scientific Sessions
|
Jun 22 |
Altimmune Presents Data on the Effect of Pemvidutide on Cardioinflammatory Lipids during Oral Presentation at American Diabetes Association’s 84th Annual Scientific Sessions
|